Synthesis and preliminary antihyperlipidaemic activities evaluation of andrographolide derivatives

Medicinal Chemistry

Volumn 8, Issue 2, 2012, Pages 293-298

  Wang, Bin ^a,b   Tang, Chunlei ^a   Han, Yaodan ^a   Guo, Ruzhou ^a   Qian, Hai ^a   Huang, Wenlong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Technology Center   (China)

Author keywords

Andrographolide; Antihyperlipidaemic activities; Derivatives; Synthesis

Indexed keywords

3 O (2 METHOXYLPHENYLOXYISOBUTYRYL) 19 O TRITYLISOANDROGRAPHOLIDE; 3 O (2 METHYLPHENYLOXYISOBUTYRYL) 19 O TRITYLISOANDROGRAPHOLIDE; 3 O (2 NAPHTHOXYISOBUTYRYL) 19 O TRITYLISOANDROGRAPHOLIDE; 3 O (3 METHYLPHENYLOXYISOBUTYRYL) 19 O TRITYLISOANDROGRAPHOLIDE; 3 O (4 BROMOPHENYLOXYISOBUTYRYL) 19 O TRITYLISOANDROGRAPHOLIDE; 3 O (4 CHLOROPHENYLOXYISOBUTYRYL) 19 O TRITYLISOANDROGRAPHOLIDE; 3 O (4 FLUOROPHENYLOXYISOBUTYRYL) 19 O TRITYLISOANDROGRAPHOLIDE; 3 O (4 METHYLPHENYLOXYISOBUTYRYL) 19 O TRITYLISOANDROGRAPHOLIDE; 3 O (4 NITRYLPHENYLOXYISOBUTYRYL) 19 O TRITYLISOANDROGRAPHOLIDE; 3 O (4 TERT BUTYLPHENYLOXYISOBUTYRYL) 19 O TRITYLISOANDROGRAPHOLIDE; 3 O PHENYLOXYISOBUTYRYL 19 O TRITYLISOANDROGRAPHOLIDE; ANDROGRAPHOLIDE; ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERLIPIDEMIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; IN VIVO STUDY; LIPID OXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84861923771     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340612800493629     Document Type: Article

References (20)

1. Sashidhara, K.V.; Kumar, A.; Kumar, M.; Srivastava, A.; Puri, A. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives. Bioorg. Med. Chem. Lett., 2010, 20(22), 6504-6507
2. Warnholtz, A.; Mollnau, H.; Heitzer, T.; Kontush, A.; Möller-Bertram, T.; Lavall, D.; Giaid, A.; Beisiegel, U.; Marklund, S.L.; Walter, U.; Meinertz, T.; Munzel, T. Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits. J. Am. Coll. Cardiol., 2002, 40(7), 1356-1363
3. Asano, S.; Ban, H.; Kino, K.; Ioriya, K.; Muraoka, M. Synthesis and structure-activity relationships of N-(4-amino-2,6-diisopropylphenyl)-N'-(1,4- diarylpiperidine-4-yl)methylureas as anti-hyperlipidemic agents. Bioorg. Med. Chem., 2009, 17(13), 4636-4646
4. Cicero, A.; Ertek, S. Natural sources of antidyslipidaemic agents: is there an evidence-based approach for their prescription? Mediterr. J. Nutr. Metab., 2008, 1(2), 85-93
5. Ulbricht, C.; Basch, E.; Szapary, P.; Hammerness, P.; Axentsev, S.; Boon, H.; Kroll, D.; Garraway, L.; Vora, M.; Woods, J. Guggul for hyperlipidemia: A review by the Natural Standard Research Collaboration. Complement Ther. Med., 2005, 13(4), 279-290 (Pubitemid 43024873)
6. Mishra, S.K.; Sangwan, N.S.; Sangwan, R.S. Andrographis paniculata (Kalmegh): A review. Pharmaco. Rev., 2007, 283-298
7. Maiti, K.; Gantait, A.; Mukherjee, K.; Saha, B.P. Therapeutic potentials of andrographolide from Andrographis paniculata: a review. J. Nat. Remedies, 2006, 6, 1-13
8. Chen, J.H.; Hsiao, G.; Lee, A.R.; Wu, C.C.; Yen, M.H. Andrographolide suppresses endothelial cell apoptosis via activation of phosphatidyl inositol-3-kinase/Akt pathway. Biochem. Pharmacol., 2004, 67(7), 1337-1345 (Pubitemid 38315099)
9. Collins, T.; Cybulsky, M.I. NF-B: pivotal mediator or innocent bystander in atherogenesis? J. Clin. Invest., 2001, 107(3), 255-264 (Pubitemid 32157955)
10. Nanduri, S.; Pothukuchi, S.; Rajagopal, S.; Akella, V.; Pillai, S.B.K.; Chakrabarti, R. Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them. India. Patent WO2001085710A1, Jan 11, 2011
11. Nanduri, S.; Rajagopal, S.; Pothukuchi, S.; Pillaj, S.B.K.; Chakrabarti, R. Compounds having antitumor actnity: process for their preparation and pharmaceutical compositions containing them. India. Patent WO2001057026A1, Jan 11, 2011
12. Wang, X.Y.; Wu, X.M.; Huang, W.L.; Zhou, J.P. Synthesis and antitumor activity of isoandrographolide derivatives. J. China Pharmaceut Univ., 2005, 36(6), 504-510
13. Li, J.; Huang, W.L.; Zhang, H.B.; Wang, X.Y.; Zhou, H.P. Synthesis of andrographolide derivatives and their TNF-a and IL-6 expression inhibitory activities. Bioorg. Med. Chem. Lett., 2007, 17(24), 6891-6894 (Pubitemid 350061293)
14. Wang, B.; Ge, L.; Huang, W.L.; Zhang, H.B.; Qian, H.; Li, J.; Zheng, Y.T. Synthesis and Preliminary Anti-HIV Activities of Andrographolide Derivatives. Med. Chem., 2010, 6(4), 252-258
15. Emblidge, J.P.; DeLorenzo, M.E. Preliminary risk assessment of the lipid-regulating pharmaceutical clofibric acid, for three estuarine species. Environ. Res., 2006, 100(2), 216-226 (Pubitemid 43155274)
16. Vaidya, H.; Rajani, M.; Sudarsanam, V.; Padh, H.; Goyal, R. Antihyperlipidaemic activity of swertiamarin, a secoiridoid glycoside in poloxamer-407-induced hyperlipidaemic rats. J. Nat. Med., 2009, 63(4), 437-442
17. Pramanick, S.; Banerjee, S.; Achari, B.; Das, B.; Sen, A.K.; Mukhopadhyay, S.; Neuman, A.; Prange, T. Andropanolide and Isoandrographolide, Minor Diterpenoids from Andrographis paniculata: Structure and X-ray Crystallographic Analysis. J. Nat. Prod., 2006, 69(3), 403-405
18. Pan, D.D.; Zhang, D.Z. Function and safety assessment of Lactococus lactis subsp. lactis LB12 as potential probiotic strain. Afr. J. Biotechnol., 2008, 7(22), 4037-4044
19. Shen, L.; Zhang, Y.; Wang, A.; Sieber-McMaster, E.; Chen, X.; Pelton, P.; Xu, J.Z.; Yang, M.; Zhu, P.; Zhou, L. Synthesis and structure-activity relationships of thiadiazole-derivatives as potent and orally active peroxisome proliferator-activated receptors / dual agonists. Bioorg. Med. Chem., 2008, 16(6), 3321-3341 (Pubitemid 351418175)
20. Khanna, A.K.; Rizvi, F.; Chander, R. Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. J. Ethnopharmacol., 2002, 82(1), 19-22.